You are here

  • Home
  • Archive
  • Volume 104, Issue 4
  • Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

Article metrics

Article menu

Download PDFPDF

Clinical science
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in neovascular age-related macular degeneration in Europe: SAFARI study

 

Online download statistics by month:

Online download statistics by month: August 2019 to March 2024

AbstractFullPdf
Aug 2019855845224
Sep 201964365477
Oct 201928527455
Nov 201911411239
Dec 201912011627
Jan 202011510832
Feb 20201009836
Mar 202026025779
Apr 202036635989
May 202031631181
Jun 202011211032
Jul 202019519235
Aug 2020666233
Sep 202010410119
Oct 2020898727
Nov 2020939026
Dec 2020988623
Jan 2021736825
Feb 2021434020
Mar 2021746918
Apr 2021464519
May 2021645817
Jun 2021474425
Jul 2021373613
Aug 2021444217
Sep 2021443718
Oct 2021494336
Nov 2021575335
Dec 2021393821
Jan 2022575222
Feb 2022383615
Mar 2022595416
Apr 2022474322
May 2022514923
Jun 2022606011
Jul 2022464618
Aug 2022615622
Sep 2022535213
Oct 2022464214
Nov 2022403619
Dec 2022201710
Jan 2023282314
Feb 2023535211
Mar 2023474711
Apr 2023424021
May 2023423521
Jun 2023423514
Jul 2023413917
Aug 2023474321
Sep 2023383018
Oct 2023494410
Nov 2023544814
Dec 2023333216
Jan 2024302925
Feb 2024302722
Mar 20243027110
Total573255291748